Institute of Protein Research, College of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
Acta Biochim Biophys Sin (Shanghai). 2010 May 15;42(5):358-62. doi: 10.1093/abbs/gmq024.
The human immunodeficiency virus-1 (HIV-1) envelope glycoprotein 120 (gp120) binds to cell surface receptors and mediates HIV entry. Previous studies suggest the cell surface protein disulfide isomerase (PDI) might interact with disulfide bond(s) of gp120 and thus facilitate HIV-1 entry. In the present study, a kinetic trapping approach was used to capture the disulfide cross-linking intermediate between gp120 and PDI. Active site mutant PDIs were prepared in which the C-terminal cysteine at the active site was replaced by a serine. The active site mutant PDIs were able to covalently cross-link with gp120 through a mixed disulfide bond in vitro. The cross-linking efficiency was enhanced by CD4 protein (primary receptor of HIV-1) and was inhibited both by bacitracin (a PDI inhibitor) and by catalytically inactive PDI. The present results suggested the cell surface PDI might play a role in HIV entry in vivo.
人类免疫缺陷病毒-1(HIV-1)包膜糖蛋白 120(gp120)与细胞表面受体结合并介导 HIV 进入。先前的研究表明,细胞表面蛋白二硫键异构酶(PDI)可能与 gp120 的二硫键相互作用,从而促进 HIV-1 进入。在本研究中,使用动力学捕获方法捕获 gp120 和 PDI 之间的二硫键交联中间体。制备了活性位点突变的 PDIs,其中活性位点的 C 末端半胱氨酸被丝氨酸取代。活性位点突变的 PDIs 能够通过混合二硫键在体外与 gp120 共价交联。CD4 蛋白(HIV-1 的主要受体)增强了交联效率,并且巴曲酶(PDI 抑制剂)和无催化活性的 PDI 均抑制了交联效率。本研究结果表明,细胞表面 PDI 可能在体内 HIV 进入中发挥作用。